We think you have liked this presentation. If you wish to download it, please recommend it to your friends in any social system. Share buttons are a little bit lower. Thank you!
Presentation is loading. Please wait.
Published byAllison Morrow
Modified over 3 years ago
FUNGAL KERATITIS IN MAN Andrew Tullo Royal Eye Hospital, Manchester
INCIDENCE OF FUNGAL KERATITIS (FK) Developed world 6 -35% of all microbial keratitis Developing world 22 - >50% Thomas PA Eye 2003;7:852
FUNGAL GROUPS Filamentous - Aspergillus - Fusarium - Dematiaceous Yeasts - Candida Garg et al Cornea 2004;23:571
FACTORS IN PATHOGENESIS Injury, ocular surface compromise Temperature Wind Humidity Urbanisation/employment
DIAGNOSIS Clinical features (diff.diagnosis) Microbiology Histopathology DNA amplification
ASPERGILLUS AND CORNEAL FOREIGN BODY 3 cases Medical cure (1), surgical cure (2) All required hospitalisation All had lasting visual impairment Fahad et al Br J Ophthalmol 2004;88:847
DIAGNOSIS Clinical features Microbiology Histopathology DNA amplification
DIAGNOSIS Clinical features Microbiology Histopathology DNA amplification
HISTOPATHOLGY Haematoxylin and eosin (H&E) Periodic acid-Schiff (PAS) Grocott
DIAGNOSIS Clinical features Microbiology Histopathology DNA amplification Gaudio et al Br J Ophthalmol 2002;86:755
OPTIMAL MANAGEMENT 1 low threshold of suspicion biopsy even when scrape is negative appropriate topical therapy ?intracameral injection Kaushik et al Cornea 2001;20:715
ANTIFUNGAL AGENTS 1 Natamycin Amphotericin B Flucytosine Azoles
AZOLES Clotrimazole Miconazole Econazole Ketoconazole Itraconazole Fluconazole Voriconazole?
OPTIMAL MANAGEMENT 2 avoidance of topical steroid? early surgery (up to 30%) systemic medication
OUTCOME Severity - delay in diagnosis - genus of fungus Treatment - compliance - toxicity - availability
CONCLUSION FK rare in UK but ?increasing Outcome dictated by diagnosis, species and management Optimal treatment may include surgery, better medication and intracameral injection
Dr. Revathi Rajaraman Aravind Eye Hospital Coimbatore
Management of Mycotic Keratitis
Outcome of therapeutic keratoplasty in fungal keratitis Sonika Gupta, MS Assistant Professor, GMCH, Chandigarh, India Author has no financial interest.
A Case of Beauveria Bassiana Keratitis Confirmed by Gene Sequencing Sung-Dong Chang, M.D., Jong-Hwa Jun, M.D. Department of Ophthalmology, School of Medicine,
ID: 287 Fusarium keratitis in a tertiary eye care centre in India Sujata Das, MS, FRCS Savitri Sharma, MD Samir Mahapatra, MS Srikant K Sahu, MS L V Prasad.
EVALUATION OF INTRA-CORNEAL INJECTION OF 5% NATAMYCIN FOR THE TREATMENT OF FUSARIUM KERATITIS Fani Segev MD, Guy Tam MD, Yossi Paitan PhD, Dvora Kidron.
Diversity of Fungi and Fungal Infections
Amit Gupta, MS Swapnil M. Parchand, MBBS Jagat Ram, MS Arunaloke Chakrabarti, MD Amod Gupta, MS Advanced Eye Centre, Post Graduate Institute of Medical.
Incidence and outcomes of Pigmented versus Nonpigmented fungal keratitis - A Retrospective analysis Dr. Thiruvengada Krishnan, M.D. Aravind Eye Hospital.
Therapeutic Penetrating Keratoplasty in Fungal Keratitis: Prospective Study Sonika Gupta Consultant Ophthalmology Max Eye Care New Delhi, India Author.
Lecturer name: Dr. Ahmed M. Albarrag Lecture Date: Oct-2012 Lecture Title: Diversity of Fungi and Fungal Infections (Foundation Block, Microbiology)
NAJRAN UNIVERSITY College of Applied Medical Sciences NAJRAN UNIVERSITY College of Applied Medical Sciences General Microbiology Course Lecture No. 23.
FACTORS INFLUENCING THE OUTCOME OF THERAPEUTIC PENETRATING KERATOPLASTY FOR MYCOTIC & SUPPURATIVE KERATITIS Philip A. Thomas J.Kaliamurthy C.A.Nelson Jesudasan.
Experience With Microbial Keratitis After Boston Type I Keratoprosthesis Implantation Cornea & Anterior Segment Services, L V Prasad Eye Institute, Hyderabad,
Bilateral Corneal Trophic Ulcers and Subsequent Infectious Keratitis in a Patient with Graft-versus-host Disease Yonca Aydın Akova, MD Bayındır Hospital,
Intracameral Amphotericin B in Management of Candida Glabrata Keratouveitis after Penetrating Keratoplasty Petra Schollmayer, Aleksandra Kraut, Mojca Globocnik-Petrovic,
Fungal infections 400 out of 75,000 Primary infections Opportunistic infections Myco-toxins Allergy.
Elvin H. Yildiz, Yasmine F. Abdalla, Ahmed F. Elsahn, Christopher J. Rapuano, Kristin M. Hammersmith, Peter R. Laibson, Elisabeth J. Cohen Cornea Service,
Fungal Infections, Pathogenesis and Treatment
Mycology Lec. 2 Dr. Manahil
Copyright restrictions may apply JAMA Ophthalmology Journal Club Slides: Mycotic Ulcer Treatment Trial Prajna NV, Krishnan T, Mascarenhas J, et al; Mycotic.
Microsporidial Stromal Keratitis : Dilemma in Clinical Diagnosis Swapnali Sabhapandit, MS Prashant Garg, MD Somasheila Murthy, MS Geeta K Vemuganti, MD.
Pharmacology-4 PHL 425 Sixth Lecture By Abdelkader Ashour, Ph.D. Phone:
Multi-Drug Resistant Pseudomonas Keratitis Clinical Characteristics and Associated Features Jayesh Vazirani Merle Fernandes L V Prasad Eye Institute Visakhapatnam,
Lecturer name: Dr. Ahmed M. Albarrag Lecture Date: Oct-2011 Lecture Title: Diversity of Fungi and Fungal Infections (Foundation Block, Microbiology)
Phialemonium obovatum keratitis after penetration injury of the cornea Kwon-Ho Hong, M.D., Sung-Dong Chang, M.D. Department of Ophthalmology, School of.
Before and after slides: -Less text and bullets-more pictures -Make pictures the center and not the text -Use nice large high-definition pictures -No more.
Lab-6- Fungi in Tissue.
The Etiologic Diagnosis of Corneal Ulcers at a Tertiary Eye Center in Kathmandu, Nepal. Michael R. Feilmeier, MD Geoffrey C. Tabin, MD Kavitha R. Sivaraman,
FUNGUS EYE DISEASE Blepharitis Keratitis POHS Endophthalmitis Orbital disease.
Elmira Baghdasaryan1,2, M.D. Sophie X. Deng1, M.D., Ph.D.
Systemic & Topical Some are fungistatic, while others are fungicidal.
CHAPTER 10-3 Dr. Dipa Brahmbhatt VMD MpH
Predisposing Factors, Microbial Characteristics, and Clinical Outcome of Microbial Keratitis in Hong Kong: A 10-Year Experience Alex LK Ng, Ian YH Wong.
By Dr.Mohamed Abd AlMoneim Attia
OPPORTUNISTIC FUNGAL INFECTIONS
Dr C Sriruttan Clinical Microbiology & Infectious Disease /11/20161 Principles & Approach.
Cryptococcal pneumonia and meningitis. Cryptococcus neoformans.
Managing Candidemia JEANNE FORRESTER, PHARMD, BCPS PGY2 INFECTIOUS DISEASES PHARMACY RESIDENT MEDICAL UNIVERSITY OF SOUTH CAROLINA.
Oropharyngeal Candidiasis in Patients with AIDS
Paecilomyces Fungal Keratitis: Combining Multiple Strategies to Improve the Outcome of Severe, Pesticide-Associated Fungal Keratitis Jonathan Etter, MD,
ANTIFUNGAL DRUGS PHARM 514 Douglas Black, Pharm.D. Associate Professor School of Pharmacy University of Washington
Self induced ocular surface injuries caused by careless handling of topical agents Faik Oruçoğlu (Orucov) Kudret Eye Hospital / Istanbul.
Ocular Candidiasis Rupesh Agrawal, Carlos Pavesio Moorfields Eye Hospital, NHS Foundation Trust, London, United Kingdom.
Treatment of Aspergillosis John R. Perfect Duke University Medical Center.
Lecturer name: Dr. Ahmed M. Albarrag Lecture Date: Oct-2012
Department of Cornea, Cataract & Refractive Surgery and *Ocular Microbiology Dr Rajendra Prasad Centre For Ophthalmic Sciences, AIIMS Dr. Manoj Sharma,
Fungal Infection in the ICU
© 2017 SlidePlayer.com Inc. All rights reserved.